190 related articles for article (PubMed ID: 33832113)
21. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Valk B; Bender B
Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
[TBL] [Abstract][Full Text] [Related]
22. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
Buckley JE; Landis LN; Rapini RP
JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
[TBL] [Abstract][Full Text] [Related]
23. Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.
Alame MM; Chamsy DJ; Zaraket H
Br J Clin Pharmacol; 2018 May; 84(5):1077-1080. PubMed ID: 29520857
[TBL] [Abstract][Full Text] [Related]
24. Pityriasis rosea.
Stulberg DL; Wolfrey J
Am Fam Physician; 2004 Jan; 69(1):87-91. PubMed ID: 14727822
[TBL] [Abstract][Full Text] [Related]
25. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
Wang CS; Chen HH; Liu SH
J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
[TBL] [Abstract][Full Text] [Related]
26. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6.
Watanabe T; Kawamura T; Jacob SE; Aquilino EA; Orenstein JM; Black JB; Blauvelt A
J Invest Dermatol; 2002 Oct; 119(4):793-7. PubMed ID: 12406322
[TBL] [Abstract][Full Text] [Related]
27. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology.
Drago F; Broccolo F; Rebora A
J Am Acad Dermatol; 2009 Aug; 61(2):303-18. PubMed ID: 19615540
[TBL] [Abstract][Full Text] [Related]
28. An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris.
Sahni MK; Roy K; Asati DP; Khurana U
Int J Risk Saf Med; 2021; 32(4):261-264. PubMed ID: 34420983
[TBL] [Abstract][Full Text] [Related]
29. [How should a pruritic pityriasis rosea Gibert be treated?].
Ann Dermatol Venereol; 1998 Dec; 125(12):955-7. PubMed ID: 10200116
[No Abstract] [Full Text] [Related]
30. HHV 6-7 reactivation causing Pityriasis Rosea and labyrinthitis: A case report.
El-Hussein M; El-Tawil C; Nakhle R; Souaiby N
Am J Emerg Med; 2020 Sep; 38(9):1969.e1-1969.e3. PubMed ID: 32553563
[TBL] [Abstract][Full Text] [Related]
31. Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea.
Kim DH; Cho JH; Park SJ; Seo SH; Ahn HH
J Korean Med Sci; 2022 Jun; 37(24):e190. PubMed ID: 35726143
[TBL] [Abstract][Full Text] [Related]
32. Detection of human herpesvirus 8 in the skin of patients with pityriasis rosea.
Prantsidis A; Rigopoulos D; Papatheodorou G; Menounos P; Gregoriou S; Alexiou-Mousatou I; Katsambas A
Acta Derm Venereol; 2009 Nov; 89(6):604-6. PubMed ID: 19997691
[TBL] [Abstract][Full Text] [Related]
33. Pityriasis Rosea: Diagnosis and Treatment.
Villalon-Gomez JM
Am Fam Physician; 2018 Jan; 97(1):38-44. PubMed ID: 29365241
[TBL] [Abstract][Full Text] [Related]
34. Investigation of herpes simplex virus DNA in pityriasis rosea by polymerase chain reaction.
Bozdag KE; Güven FO; Zeytinoglu A; Erensoy S; Karaman A; Bilgiç A
Int J Dermatol; 2005 Jun; 44(6):477-8. PubMed ID: 15941434
[TBL] [Abstract][Full Text] [Related]
35. Pityriasis rosea developing after COVID-19 vaccination.
Marcantonio-Santa Cruz OY; Vidal-Navarro A; Pesqué D; Giménez-Arnau AM; Pujol RM; Martin-Ezquerra G
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e721-e722. PubMed ID: 34237178
[No Abstract] [Full Text] [Related]
36. Atypical pityriasis rosea and Hodgkin's disease.
Garcia-F-Villalta MJ; Hernández-Nuñez A; Córdoba S; Fernández-Herrera J; García-Díez A
J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):81-2. PubMed ID: 14678538
[TBL] [Abstract][Full Text] [Related]
37. Vesicular pityriasis rosea: an atypical presentation.
Balci DD; Hakverdi S
Dermatol Online J; 2008 Mar; 14(3):6. PubMed ID: 18627708
[TBL] [Abstract][Full Text] [Related]
38. Pityriasis Rosea in Kaduna, North-West Nigeria: A 20-Year Experience.
Yahya H
West Afr J Med; 2023 Jul; 40(7):704-710. PubMed ID: 37515778
[TBL] [Abstract][Full Text] [Related]
39. Localized pityriasis rosea.
Ahmed I; Charles-Holmes R
Clin Exp Dermatol; 2000 Nov; 25(8):624-6. PubMed ID: 11167977
[TBL] [Abstract][Full Text] [Related]
40. Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?
Martora F; Picone V; Fornaro L; Fabbrocini G; Marasca C
J Med Virol; 2022 Apr; 94(4):1292-1293. PubMed ID: 34931329
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
